Friday, October 8, 2021

Gel enhances CAR-T immunotherapy benefits in brains surgically treated for glioblastoma

Researchers report that pairing a newly developed fibrin gel with CAR-T immunotherapy that was delivered to post-surgical mouse brains with glioblastoma improved the immunotherapy's effectiveness. The gel aided CAR-T cell distribution in the brain by acclimating the T cells to the post-surgical wound environment while also stopping the tumor from recurring.

from Top Health News -- ScienceDaily https://ift.tt/3llpHfq
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Kratom poison center cases have surged 6,500% in the U.S.

Kratom use and serious health problems linked to it have risen dramatically across the United States over the past decade. Poison center rep...